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CalciumThe permeability transition pore (PTP) is a large channel of the mitochondrial inner membrane, the opening of
which is the central event inmany types of stress-induced cell death. PTP opening is induced by elevated concen-
trations of mitochondrial calcium. It has been demonstrated that spermine and other polyamines can delay
calcium-induced swelling of isolated mitochondria, suggesting their role as inhibitors of the mitochondrial PTP.
Here we further investigated the mechanism by which spermine inhibits the calcium-induced, cyclosporine A
(CSA)— sensitive PTP by using three indicators: 1) calcium release from themitochondria detectedwith calcium
green, 2) mitochondrial membrane depolarization using TMRM, and 3) mitochondrial swelling by measuring
light absorbance. We found that despite calcium release and membrane depolarization, indicative of PTP activa-
tion, mitochondria underwent only partial swelling in the presence of spermine. This was in striking contrast to
the high-amplitude swelling detected in controlmitochondria and inmitochondria treatedwith the PTP inhibitor
CSA. We conclude that spermine selectively prevents opening of the high-conductance state, while allowing ac-
tivation of the lower conductance state of the PTP. We propose that the existence of lower conductance, stress-
induced PTPmight play an important physiological role, as it is expected to allow the release of toxic levels of cal-
cium, while keeping important molecules (e.g., NAD) within the mitochondrial matrix.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Permeability transition (PT) is a phenomenon of dramatically in-
creased permeability of the inner mitochondrial membrane, which
can lead to the loss of mitochondrial function and cell death [5,8,27,
55]. The PT was ﬁrst described by Hunter and colleagues [21] as a
high-amplitude swelling of energized, isolated mitochondria in re-
sponse to the addition of calcium. They concluded that large amounts
of calcium accumulated in mitochondria induce an increase in the
permeability of the inner mitochondrial membrane (i.e., PT), which be-
comes non-selectively permeable to ions and solutes. Later, electro-
physiological studies established that PT is caused by opening of the
channel PT pore (PTP) in the mitochondrial inner membrane [25,26,
36,45,46]. The fully open PTP allows passage of molecules up to
1500 Da. Functional studies suggest that in addition to the fully open
state, the PTP has a number of sub-conductance states, and can function
in lower-conductance modes [26,47]. The low-conductance mode was
proposed to be essential for the normal functioning of the cell
under conditions of low calcium concentrations [22,23]. The high-
conductance mode of the PTP is predominant during the exposure ofgy and Biophysics, Dalhousie
x: +1 902 494 1685.the cell to certain stresses, like calcium overload and oxidative
stress and is believed to be the primary cause of necrotic cell death [8].
The opening of the PTP can be selectively inhibited by the
immunosuppressor cyclosporin A (CSA), which targets cyclophilin D
[18]. Electrophysiological patch-clamp studies of native mitoplasts, as
well as puriﬁed PTP components conﬁrmed that the PTP has a number
of stable sub-conductance states, of which a half-conductance state is
predominant [34,46]. In fact, the PTP channel was initially termed as
the Multi-Conductance Channel [25,26]. Although both high- and low-
conductance states are present in patch clamp experiments, at the
level of intact mitochondria during excessive calcium overload, howev-
er, only the high-conductance state of the PTP has been described.
Spermine is a biological organic polymer that has four primary
amino groups. It is present in both prokaryotic and eukaryotic cells,
where it is involved in the regulation of transcription [38], enzymatic
activity and the cell cycle [54]. It has also been shown that spermine
can be taken up by the mitochondria [50–52], where it plays a role in
the regulation of enzymatic activity and free radical scavenging [37,
40]. Furthermore, polyamines can inhibit calcium-induced mitochon-
drial swelling [31,32,39], suggesting their involvement in regulation of
the PTP. Recent studies established that spermine can bind inorganic
polyphosphate (polyP) with high afﬁnity [44]. PolyP is a potent
activator [1,42,43], and possibly a structural component of the
calcium-induced PTP [34]. This raises the attractive possibility that the
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polyP activation of the PTP.
Here, we demonstrate that spermine inhibits the high-conductance
mode of PTP, which is required for induction of high-amplitude mito-
chondrial swelling in sucrose-based media. However, spermine did
not inhibit the low-conductancemode PTP, whichwas deﬁned asmito-
chondrial membrane depolarization and calcium release in the absence
of high-amplitude swelling. These data are consistent with distinct reg-
ulation and/or nature of the different states of the PTP.
2. Experimental procedures
2.1. Animals
Sprague–Dawley rats were purchased from Charles River and
housed in a climate-controlled environment with appropriate light:
dark cycles. Rats were allowed to eat standard chow and water ad
libitum. All procedures were approved by the Animal Care Committee
of Dalhousie University and conformed to the standards of the Canadian
Council on Animal Care.
2.2. Reagents
Tetramethylrhodamine methylester (TMRM) was purchased from
Invitrogen. All other reagents were purchased from Sigma Aldrich.
2.3. Mitochondrial isolation
Rat liver mitochondria were isolated as described previously [13].
Brieﬂy, the rat liver was homogenized in mitochondrial isolation buffer
(300 mM Sucrose, 5 mM Tris–HCl, 2 mM EDTA, 0.5 mg/ml BSA, pH 7.4)
and isolated by differential centrifugation.
2.4. Protein assay
Isolated mitochondria were resuspended in 2 ml of 1 M NaOH.
Samples were homogenized and incubated at 4 °C with constant ag-
itation for 30 min, then centrifuged at 12,000 ×g for 15 min. Protein
concentration was determined in the supernatant of each sample
with a modiﬁed Lowry method (Bio-Rad DC Protein Assay, Cat #
500–0116).
2.5. Mitochondrial PTP induction
PTP was induced by the addition of calcium to energized mitochon-
dria. Brieﬂy, energized isolated mitochondria (1 mg/ml of protein) in
sucrose-based recording buffer (210 mM mannitol, 70 mM sucrose,
0.2 mM KH2PO4, 5 mM Tris–HCl, 0.8 μM rotenone, 5 mM succinate,
pH 7.4) were treated either with 100 μM of CaCl2 alone or in combina-
tion with 1 μM of CSA, or spermine (0.1–2 mM). The opening of the
PTP was measured by three independent approaches: 1) calcium re-
lease from themitochondria detectedwith calciumgreen 5N (1 μM; ex-
citation 506 nm, emission 532 nm); 2) mitochondrial membrane
depolarization using TMRMprobe (0.1 μM; excitation 546 nm, emission
590 nm) as previously described [13,41]. This method relies on the
quenching of TMRM accumulated inside polarized mitochondria.
When mitochondria become depolarized, TMRM is released into the
media causing the overall increase in ﬂuorescent signal; and 3) mito-
chondrial swellingmeasured as a decrease of light absorbance. The spe-
ciﬁc signal detected in these experiments is the intensity of the light
passing through the recording cuvette. Under conditions of mitochon-
drial swelling, the mitochondrial matrix becomes less dense, and more
light can pass through (i.e., the media becomes less light-absorbing)
and thus the intensity of transmitted light increases. The intensity of
light directly passing through the cuvette was recordedwith both emis-
sion and detection wavelengths set at 540 nm with an in housemodiﬁed Quantamaster-4 Spectroﬂuorimeter (PTI, Birmingham, NJ).
In themitochondrial swelling/light absorbance experiments, noﬂuores-
cent probe was used. Unless indicated otherwise, complete mitochon-
drial swelling was achieved by the addition of 5 μM of alamethicin.
Data was analyzed with FelixGX software (PTI, Birmingham, NJ).
2.6. Electron microscopy
Following treatment with either calcium alone, calcium plus
spermine or control without calcium and without spermine, samples
were ﬁxed in 2.5% glutaraldehyde in sucrose buffer and processed in
the EM Facility Core (Dalhousie University). Brieﬂy, the samples were
centrifuged and rinsed 3 times in 0.1 M sodium cacodylate buffer and
ﬁxed in 1% osmium tetroxide for 2 h and, after dehydration, embedded
in epon araldite resin. Approximately 100-nm thick sections were cut
with an ultramicrotome and placed on 300 mesh copper grids, which
were stained with 2% aqueous uranyl acetate, rinsed and treated with
lead citrate, then rinsed and air dried. Images were captured with a
Jeol Jem 1230 transmission electron microscope at 80 kV with Hamatsu
ORCA-HR digital camera attached to the microscope.
2.7. Respirometry
Isolated rat liver mitochondrial respiratory oxygen ﬂux (JO2) was
measured in high resolution, concurrent with ﬂuorometric signal for
calcium green 5 N, using the Oxygraph-2k with O2k-Fluorescence
LED2-Module (OROBOROS Instruments, Innsbruck, AT). All mitochon-
drial samples were assessed in 2 ml of assay buffer, consisting of
210 mM of mannitol, 70 mM of sucrose, 0.2 mM of KH2PO4, 5 mM of
Tris–HCl, and pH 7.4. The concentration of O2 in the experimental cham-
bers was maintained between 10 and 200 μM. All experiments were
conducted at 25 °C. Instrumental background O2 consumption was
corrected using equations determined under the same parameters
used for experimental data collection. In the presence or absence of
0.2mM of spermine, respirationwas initiatedwith 10mMof glutamate
and +4 mMmalate. After JO2 stabilization, PTP induction was initiated
by addition of 50 μM CaCl2, with calcium uptake and release conﬁrmed
by ﬂuorometric signal. 1 mM of EGTAwas added to determinewhether
PTP could be subsequently reversed by chelation of calcium (conﬁrmed
in ﬂuorometric signal).
3. Results
3.1. Spermine inhibition of the PTP
In order to establish the appropriate conditions inwhich to study the
mechanisms of action of spermine, isolated energized mitochondria
(1 mg/ml of protein) were treated with different doses of spermine
(10 to 200 μM) and challengedwith either 100 μMor 200 μMof calcium.
Calcium-induced PTP opening was ﬁrst studied with mitochondrial
swelling, detected as an increase of the intensity of transmitted light
due to the decrease in absorbance at 540 nm [20]. Under these experi-
mental settings, themaximal light intensity corresponds to theminimal
absorbance of the media. Calcium-induced swelling was inhibited by
spermine in a dose-dependent manner (Fig. 1A and B and Supplemen-
tary Fig. 1). In Fig. 1B the degree of inhibition was estimated from the
value of light intensity at the end of experiment and normalized to
light intensity in the presence of alamethicin (100%, completely swollen
mitochondria) using the initial intensity of light as no swollen mito-
chondria (0%, completely intact mitochondria). Note that under the ex-
perimental conditions in Fig. 1A swellingwas inhibited only partially. At
concentrations higher than200 μM, spermine also blocked the transport
of calcium into the mitochondria (data not shown). Thus, higher con-
centrations of spermine were not used in our experiments. Notably, in
experiments with 100 μM of calcium in the presence of high spermine
concentrations we did not see any noticeable increase in swelling
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experimental protocol and amounts of calcium that were used in this
section, spermine not only inhibited swelling but also inhibited mem-
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Next, we compared the effects of spermine versus CSA on PTP inhi-
bition. To test these effects, the PTP was assayed by measuring
calcium-induced swelling (Fig. 2A), calcium release (Fig. 2D–F) and
mitochondrial membrane potential depolarization (Fig. 2G–I). As illus-
trated in Fig. 2A (control trace), addition of 25 μM calcium induced
near-complete mitochondrial swelling in untreated samples, with only
moderate further swelling elicited by addition of pore-forming
alamethicin. For isolated mitochondria treated with CSA (Fig. 2A, CSA
trace), 4 additions of 25 μM calcium were required to induce swelling.
Despite the requirement for greater calcium concentration, in the pres-
ence of CSA, the degree of swelling was comparable to control. In the
presence of spermine, by contrast, the concentration of calcium which
induced PTP, as evident from Fig. 2 F and I, caused only partial swelling
(Fig. 2A, spermine trace, and Fig. 2B). Importantly, in control as well as
in the presence of either CSA or spermine, mitochondria demonstrated
behavior typical of the normal PTP detected by mitochondrial calcium
release (Fig. 2 D–F) and membrane depolarization (Fig. 2 G–I). The ob-
servation that calcium challenge resulted in mitochondrial calcium re-
lease and membrane depolarization, but not swelling in spermine-
treated samples, suggests that spermine prevents the high-amplitude
swelling typical of high-conductance PTP. We should note that when
moderate concentrations of calcium were used to induce swelling, the
resulted degree of swelling varied to some extend likely due to the
mode of calcium addition. For example when calcium was added in
25 μM of aliquots (rather than bulk addition) less amount was required
to induce partial swelling (compare Fig. 2A, red trace with Supplemen-
tary Fig. 1 and blue trace Fig. 2C). Further, it is possible that sensitivity of
mitochondria toward swelling can vary from preparation to prepara-
tion. These raise the possibility that partial swelling seen in our experi-
ments was due to the relatively moderate calcium load and presence of
subpopulation of intactmitochondria. To exclude the possibility that in-
complete swelling was simply due to a remaining fraction of intact mi-
tochondria in the sample, we also tested the effect of excessive calcium
(1mM) on spermine-treated samples. Evenunder these extreme condi-
tions, swelling remained incomplete (Fig. 2C), rebutting the possibility
of a remaining fraction of intact mitochondria.
3.3. Changes in mitochondrial morphology in the presence of spermine
The light scattering assay described in the previous section detects
changes in the whole population of mitochondria suspended in the cu-
vette, but does not provide information about changes at the level of the
individual organelle. To address this, we used electronmicroscopy to in-
vestigate morphological changes of the mitochondria under conditions
identical to those described in the previous section. Results of these
experiments are presented in Fig. 3. Isolated mitochondrial samples ex-
aminedwith electronmicroscopy were ﬁrst monitored using a light ab-
sorbance assay to ensure that the mitochondria achieved fully
developed PTP. Samples for electron microscopy were collected after
treatment with either calcium alone, spermine plus calcium or vehicle,
immediately prior to alamethicin addition (see Fig. 2A for the
reference). In addition to characterizing the morphology of the mito-
chondria, we also performed quantitative analysis of the electron mi-
croscopy images by counting the number of mitochondria of each
type found in the imaging ﬁeld (see representative images of the ﬁeld
in Supplementary Fig. 1). We used 3 ﬁelds for each condition, and 2
independent mitochondrial isolations. In the mitochondrial morpholo-
gy description below, we indicate the average (number of mitochon-
dria ± S.D.) of each type found per ﬁeld (images were taken at
10,000× and the ﬁelds were 196 μm2). Control mitochondria appeared
as relatively dense structures with easily recognizable cristae and dou-
ble membranes (Fig. 3 A, D (n = 3 ± 2), G (n = 30 ± 2) and J, “no
spermine, no calcium” column). Consistent with earlier reports,
calcium-treatedmitochondria that underwent high-amplitude swellingappeared as fully swollen, nearly transparent structureswith only single
membranes remaining (Fig. 3 “calcium, no-spermine” column, n =
42 ± 9) and with only small fraction of population having double-
membrane structure (n=3± 1). When PTP was activated in the pres-
ence of spermine, mitochondrial morphology differed substantially
from the transparent structures observed in calcium-treated controls
(Fig. 3). Although compared to normal mitochondria, the morphology
of the spermine-treated mitochondria was substantially altered
(Fig. 3), they still exhibited electronically dense matrix with some pre-
served internal crista structure (Fig. 3F, n= 34 ± 10). In fact, some of
the spermine-treated mitochondria exhibited morphological similari-
ties with normal controls (Fig. 3I, n= 10± 1), and only few of the mi-
tochondria (n=5±2) appeared to lose their structural integrity to the
same degree as calcium-challenged mitochondria without spermine.
Importantly, in the presence of spermine, the integrity of the outer mi-
tochondrial membrane was maintained in both types of mitochondria,
as evidenced by the presence of double membranes (see arrows,
Fig. 3F, I and L). Overall, these data support the interpretation that
spermine inhibits high-amplitude mitochondrial swelling.
3.4. Effect of ionic strength on spermine inhibition
Next, we investigated effects of spermine onmitochondrial swelling
in a solution containing 150mM of KCl in place of sucrose. Under these
conditions, mitochondrial swelling during PTP formation is due to free
diffusion of potassium and chloride ions. In this salt solution, spermine
had no effect on mitochondrial swelling (Fig. 4A). This suggests that in
the presence of spermine, the low-conductance PTP is not cation- or
anion-selective. To determine whether the effects demonstrated in
Fig. 4A are due to the ionic strength of the media, we used a recording
solution containing methyl-D-glucamine (NMDG+), a positively
charged molecule similar in size to mannitol. Including NMDG+, a
large monovalent ion, increases the ionic strength of themedia without
permeating selective, low-conductance channels. Therefore, NMDG+
will not contribute to mitochondrial swelling if a low-conductance
mechanism is activated. When the buffer media contained only
NMDG+, not even control mitochondria underwent high-amplitude
swelling (data not shown). Presumably, this was due to the combina-
tion of both the charge and size of NMDG+, as NMDG+ does not perme-
ate even the high-amplitude PTP. However, when NMDG+ buffer was
mixed in equal volumes with sucrose–mannitol buffer to allow osmotic
swelling when the PTP is open, mitochondrial swelling was observed in
control mitochondria with 100 μM of calcium. Both spermine and CSA
inhibited this calcium-induced swelling (Fig. 4B). These results support
that themechanism by which spermine prevents PTP-dependent mito-
chondrial swelling does not depend on the ionic strength of the
solution.
3.5. Spermine inhibits swelling in uncoupled mitochondria
Although spermine inhibited mitochondrial swelling in the above
experimental conditions, it was still only about 50% (as determined by
the light scattering experiments) compared with control. We hypothe-
sized that the degree of swelling in those cases might be related to the
amount of the total mitochondrial calcium load and that the degree of
swelling can be reduced if less calcium is used to trigger the PTP. To
test this, we investigated mitochondrial swelling under conditions of
mild uncoupling induced by CCCP. Under these conditions, signiﬁcantly
less calcium is required for induction of PTP. In the presence of CCCP,
spermine inhibition of swelling (Fig. 5C and F) was stronger than previ-
ously described inhibition in the absence of CCCP (Fig. 2). Notably,
under these conditions, mitochondria were depolarized and calcium
was released from the mitochondria (Fig. 5D and E). These results
suggest a relationship between calcium load and swelling, as less calci-
um is accumulated in uncoupled mitochondria. Indeed, when lower
concentrations of calcium are required for induction of PTP, as
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swelling occurs.
3.6. Mitochondrial swelling in the presence of high phosphate and spermine
Next we investigated whether inhibition of swelling by spermine is
related to its ability to increase the threshold of calcium-induced PTP ac-
tivation. To study this, we monitored mitochondrial swelling in the
presence of 1 mM phosphate. Under these conditions, spermine does
not delay the onset of calcium-dependent PTP. Indeed, spermine did
not inhibit calcium release (Fig. 6B) but almost completely inhibited
swelling (Fig. 6A). These results suggest that spermine possesses dual
inhibitory effects: one linked to the increase in mitochondrial calcium
retention capacity, and the other to the inhibition of the high-
conductance mode of PTP.A
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Our data suggest that although spermine treatment did not prevent
mitochondrial calcium release andmembrane depolarization, themito-
chondrial integrity was partially preserved (Fig. 3 F, I, L). In order to test
whether this partial protection afforded by spermine is sufﬁcient to
maintain mitochondrial respiratory function in isolated rat liver
mitochondria, the JO2 under these conditions was investigated. Using
high-resolution respirometry (Fig. 7B and D) coupled with simulta-
neous calcium green ﬂuorescence monitoring (Fig. 7A and C), mito-
chondrial respiration was assessed during routine glutamate + malate
oxidation, followed by calcium-induced PTP formation (calcium re-
lease) and closure (EGTA calcium chelation). The results demonstrate
that although it took the spermine-treated mitochondria longer than
control to release calcium (indicative of delayed PTP formation), the0 200 400
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Fig. 7. Spermine does not preserve respiratory function following calcium-induced PTP formation. Isolated livermitochondria (“Mitos”) were injected into the oxygraph chamber contain-
ing 10 mM glutamate and +4 mMmalate in physiological buffer solution alone (A and B) or containing 0.2 mM of spermine (C and D). Addition of 50 μM CaCl2 led to calcium uptake
(decrease in ﬂuorescent signal for calcium green; A and C) and eventual calcium release (increase in calcium signal). Chelation of calcium with 1 mM EGTA did not restore respiratory
function in any of the samples, as indicated by no increase in the respiratory oxygen ﬂux (B and D).
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affect respiration in either condition (Fig. 7B and D). Overall, these data
indicate that despite the prevention of swelling/PTP-related damage
with spermine in our experimental conditions,mitochondrial respirato-
ry function is not preserved.3.8. DAPI inhibits swelling
According to our previously proposed model [34], in order to be
functional, the PTP pore has to contain polyP, likely as a part of
channel-forming poly-β-hydroxybutyrate/calcium/polyP complex.
Also, PolyP is proposed to be an endogenous activator of the PTP [44].
Considering that DAPI, a ﬂuorescent probe (Fig. 8A), is capable of bind-
ing polyP [3,49], we decided to test the effect of DAPI on mitochondrial
swelling. Fig. 8C shows that DAPI inhibits mitochondrial calcium-
induced swelling in a concentration-dependent manner. Importantly,
this effect is likely not due to the ability of DAPI to inhibit calcium up-
take. Indeed, as indicated in Fig. 8D,when the calcium-sensitive Calcium
Green probe was used, both calcium uptake as well as calcium release
still occurred.4. Discussion
In the present study, the mechanisms of PTP inhibition by the poly-
amine spermine were investigated. We found that in addition to the
well-established ability of spermine to reduce the calcium sensitivity
toward PTP formation in mitochondria [31,48], spermine also blocks
high-conductance PTP activity. This effect results in mitochondrial de-
polarization and calcium release from the mitochondrial matrix. Inter-
estingly, spermine prevented mitochondrial swelling, even in the
presence of calcium levels far exceeding those minimally required for
PTP activation (Fig. 2 C). Indeed, electron microscopy conﬁrmed intact
double membranes in the majority of the spermine-treated mitochon-
dria, as well as high-density matrices after the treatment with elevated
calcium (Fig. 3C, F, I, and L). It is notable that even in the presence of the
classical PTP inhibitor CSA, high levels of calcium induced swelling to
the same degree as in control. This suggests that mechanism by which
spermine inhibits the PTP differs fundamentally from most known PTP
inhibitors (including CSA), which prevent or delay PTP opening, but
do not affect the properties of the activated channel.
Results of the present study may have particular relevance to the
proposed physiological roles of the PTP. A transient PTP opening can
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Fig. 8. Inhibition of the mitochondrial swelling by DAPI. A. Molecular structure of DAPI. B. Molecular structure of spermine. C. DAPI inhibits calcium-induced mitochondrial swelling. Iso-
latedmitochondria were treatedwith different amounts of DAPI and challengedwith 100 μMCaCl2. Swellingwasmonitored spectrophotometrically at 540 nm. At the end of each exper-
iment 5 μMof alamethicinwas added to achieve complete swelling. D. Experiments conﬁrming that DAPI did not inhibitmitochondrial calciumuptake and that calcium release still occurs.
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roles for example as calcium “release valves” [9]. In addition to accumu-
lated calcium, profound mitochondrial damage can be triggered by in-
creased mitochondrial production of reactive oxygen species (ROS)
and related oxidative stress [10,14,29]. Thus, in addition to calcium,
such transient opening of PTP could be protective by helping to decrease
the amount of ROS inside the mitochondria. It is intriguing to consider
the possibility that these transient PTP events can occur not only in
the fully open, but rather in more nuanced, sub-conductance states.
The beneﬁts of such small-conductance states of the PTP should be ap-
parent, considering that even a transient occurrence of the fully open
state of the high-conductance PTP can disrupt mitochondrial function
due to the release of physiologically important compounds from the
matrix (e.g. NAD, glutathione, etc.). We should also note that the con-
centrations of spermine used in the present study are similar to those
found in the cytoplasm [53]. Although the possibility that spermine pro-
tects mitochondria from high-conductance PTP is attractive, we were
not be able to detect a protective effect of spermine on mitochondrial
respiration — at least, not at the level of isolated liver mitochondria. In
these functional experiments, even partial swelling led to the loss of res-
piration, similar to control. However, it is possible that in the case of
transient PTP openings, protective effectswill bemoreprofound. Anoth-
er interesting physiological implication is the possible occurrence of PTP
and loss of mitochondrial function, without destruction of the outer
membrane. Presumably, in such a situation where the release of mito-
chondrial pro-apoptotic factors (e.g., cytochrome c) is prevented, mito-
chondrial death could occur without the induction of apoptosis [27].
Indeed, the effects of spermine on PTP formation are considered to
play an important role in apoptosis [53]. However, these options,
though attractive, will require further investigation.We cannot say con-
clusively what the size of this lower conductance state of PTP is ob-
served in our experiments. Taking into account that swelling still
occurs to the full extent in KCl media, we can conclude that this state
is not strongly selective between cations and anions. It is possible thatthis lower conductance state corresponds to the “half-conductance”
state observed in patch clamp experiments,which is not highly selective
[47]. We should note that initially, it was suggested that this half-
conductance statemight be linked to the presence of VDAC as an essen-
tial part of the pore. However, an essential role for VDAC in the PTPwas
not conﬁrmed by experiments involving transgenic knock-out models
[4,30]. In native PTP channels, not only sub-conductance states have
been observed, they are also consistent with the newly proposed in-
volvement of dimers of the ATP synthase PTP complex [15]. This further
supports the notion that the presence of sub-state in PTP is not neces-
sarily related to the VDAC activity.
The mechanisms by which spermine inhibits the PTP are not well-
understood. It has been proposed that spermine may mask membrane
surface charges, and in doing so, alter membrane surface potential [6].
This would explain the inhibitory effect against the onset of PTP. How-
ever, this is unlikely to result in the partial swelling observed in our
light scattering experiments. Indeed, the effects of spermine were sim-
ilar in the high and low ionic strength media (Fig. 4 B), suggesting that
themechanismof action does not depend onmembrane surface charge.
Another potential explanation for spermine'smechanismof action is
its recently discovered ability to bind inorganic polyphosphate (polyP).
PolyP is proposed to be an endogenous activator of the PTP [44]. The
molecular nature of PTP is not well-deﬁned. PTP is suggested to be a
multi-protein complex with the central part likely formed by dimers
of ATP synthase [11,15] or by the channel within its C-subunit ring [2]
(see also comment in [24]). Importantly, involvement of C-subunit in
PTP has been demonstrated at the level of live cells [56]. However the
view of the involvement of C-subunit ring is not consistent with a num-
ber of experimental observations (see [7,12,17] for details). Othermem-
brane proteins have also been implicated as parts of the complex, such
as ANT, VDAC and the phosphate carrier [19,33]. Recent review suggests
that PTP pore might be formed at the interface between ATP synthase,
ANT and Phosphate Carrier [19]. However, we should note that at
least for calcium-induced PTP in isolated mitochondria none of these
239P.A. Elustondo et al. / Biochimica et Biophysica Acta 1847 (2015) 231–240proteins proved to be essential [4,16,28]. Furthermore the physical asso-
ciation (if any) between ATP synthase and abovementioned proteins re-
mains to be established. Overall, the molecular identity of the
components essential for pore formation has not been established yet,
with no protein deﬁnitively assigned to be its pore part and is a subject
of hot debate. On the other hand, according to our previously proposed
model [34], in order to be functional, the PTP pore part does not require
to contain any proteins but has to contain polyP, likely as a part of a
channel-forming poly-β-hydroxybutyrate/calcium/polyP complex. We
propose the possibility that increased spermine concentrations can
lead to the binding of polyP and make it unavailable for binding to the
other molecular components of PTP. This would result in the inability
of the PTP channel to achieve a fully open conformation. While testing
this hypothesis will require further investigation, it should be noted
that the effects of spermine can be mimicked by the addition of DAPI
(Fig. 8). DAPI is a ﬂuorescent probe which is capable of binding polyP
[3,49]. The fact that two molecules with signiﬁcantly different chemical
structures can cause similar inhibitory effects suggests that the mecha-
nism of spermine action does not occur through interaction with some
speciﬁc binding site, but rather some relatively non-speciﬁc target. Be-
cause it can assumemultiple conformations, polyP could certainly fulﬁll
the role of such target.
The present work demonstrates pharmacological regulation of the
low- and high-conductance PTP. Different conductance states of the
PTP have been previously identiﬁed utilizing electrophysiology tech-
niques. Here, we demonstrate that PTP has at least two conductance
states that can be discerned pharmacologically at the level of the intact
mitochondria. Understanding themechanisms throughwhich spermine
and similar compounds exert their effects on PTP formation and func-
tion may lead to the discovery and development of new treatments to
prevent the damage produced by PT under pathological conditions. Fur-
thermore, these results highlight the importance of selectively regulat-
ing a channel that can disrupt the mitochondria under certain
circumstances, but may be an essential part of normal cell physiology.
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